RegulatoryApr 7, 2026, 09:11 AM
Bluejay Diagnostics Provides Update on Patient Enrollment in SYMON-II Clinical Trial
AI Summary
Bluejay Diagnostics issued a press release on April 7, 2026, providing an update on the status of patient enrollment in its ongoing SYMON-II clinical trial. This update is relevant to investors as it provides insight into the progress of a key clinical trial for the company.
Key Highlights
- Bluejay Diagnostics provided an update on patient enrollment in the SYMON-II clinical trial.
- The update was disclosed via a press release on April 7, 2026.
- The information is furnished and not filed, meaning it is not automatically incorporated by reference into other filings.
Price Impact
More from BJDX
Clinical Trial1d ago, 5:31 PM
Bluejay Diagnostics Completes SYMON-II Clinical Trial Enrollment for 750 Patients
Clinical Trial2d ago, 6:33 AM
Bluejay Diagnostics Completes Enrollment for SYMON-II Clinical Study
AGM/EGMJun 9, 5:31 PM
Bluejay Diagnostics Stockholders Approve Reverse Split, Increase Stock Plan Shares